These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer. Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma. Gameiro A; Almeida F; Nascimento C; Correia J; Ferreira F Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800900 [TBL] [Abstract][Full Text] [Related]
8. Molecular based subtyping of feline mammary carcinomas and clinicopathological characterization. Soares M; Madeira S; Correia J; Peleteiro M; Cardoso F; Ferreira F Breast; 2016 Jun; 27():44-51. PubMed ID: 27212699 [TBL] [Abstract][Full Text] [Related]
9. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours. Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070 [TBL] [Abstract][Full Text] [Related]
10. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study. Soares M; Correia J; Peleteiro MC; Ferreira F Tumour Biol; 2016 Mar; 37(3):4053-64. PubMed ID: 26486327 [TBL] [Abstract][Full Text] [Related]
11. Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas. Maniscalco L; Millán Y; Iussich S; Denina M; Sánchez-Céspedes R; Gattino F; Biolatti B; Sasaki N; Nakagawa T; Di Renzo MF; de Las Mulas JM; De Maria R BMC Vet Res; 2013 Apr; 9():80. PubMed ID: 23587222 [TBL] [Abstract][Full Text] [Related]
12. Adipocyte-Derived Adipokines and Other Obesity-Associated Molecules in Feline Mammary Cancer. Marshall T; Chen J; Viloria-Petit AM Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626804 [TBL] [Abstract][Full Text] [Related]
13. Feline HER2 protein expression levels and gene status in feline mammary carcinoma: optimization of immunohistochemistry (IHC) and in situ hybridization (ISH) techniques. Soares M; Correia J; Rodrigues P; Simões M; de Matos A; Ferreira F Microsc Microanal; 2013 Aug; 19(4):876-82. PubMed ID: 23718944 [TBL] [Abstract][Full Text] [Related]
14. CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors. Marques CS; Santos AR; Gameiro A; Correia J; Ferreira F BMC Cancer; 2018 Jul; 18(1):741. PubMed ID: 30012106 [TBL] [Abstract][Full Text] [Related]
15. Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma. Govoni VM; Da Silva TC; Guerra JM; Pereira IVA; Queiroga FL; Cogliati B Vet Comp Oncol; 2021 Jun; 19(2):404-408. PubMed ID: 33576549 [TBL] [Abstract][Full Text] [Related]
16. Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas. Sommerville L; Howard J; Evans S; Kelly P; McCann A Vet Comp Oncol; 2022 Jun; 20(2):535-538. PubMed ID: 35006637 [TBL] [Abstract][Full Text] [Related]
17. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer. Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study. Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524 [TBL] [Abstract][Full Text] [Related]
19. Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes. Gameiro A; Nascimento C; Urbano AC; Correia J; Ferreira F Front Vet Sci; 2021; 8():625147. PubMed ID: 33644151 [TBL] [Abstract][Full Text] [Related]
20. The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications. Nascimento C; Gameiro A; Correia J; Ferreira J; Ferreira F Cells; 2022 Aug; 11(16):. PubMed ID: 36010653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]